Clinical trial

Iressa 2nd Line Phase III Study in Japan

NCT00252707

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-09-01

PhasePHASE3

Study timeline

Study start (unknown)2003-09-01Date precision: month

Registry last updated2007-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Interventions

Gefitinib or DocetaxelDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

NagoyaAichi-ken, Japan1 SapporoHokkaido, Japan1 YokohamaKanagawa, Japan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00252707 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.